Stocktoria
KALA BIO, Inc. KALA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-07-20
KALA BIO, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER | 2025-10-23 | Sell | 967 | $0.82 |
| Iwicki Mark T | director | 2025-10-23 | Sell | 154,894 | $0.81 |
| Bazemore Todd | director | 2025-10-22 | Sell | 47,768 | $0.83 |
| Brazzell Romulus K | SEE REMARKS | 2025-10-22 | Sell | 46,748 | $0.83 |
| Kharabi Darius | CHIEF BUSINESS OFFICER | 2025-10-22 | Sell | 20,806 | $0.83 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER | 2025-10-22 | Sell | 32,230 | $0.83 |
| BAKER BROS. ADVISORS LP | 2025-10-01 | Sell | 50,640 | $1.38 | |
| BAKER BROS. ADVISORS LP | 2025-10-01 | Sell | 462,967 | $1.38 |
Source: SEC EDGAR filings · CIK 0001479419 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.